Skip to main content

#160451

143B m.8993T>G isogenic mTUNE mT70 Cell Line

Cat. #160451

143B m.8993T>G isogenic mTUNE mT70 Cell Line

Cat. #: 160451

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Human

Tissue: Bone

Disease: Cancer

Model: Tumour line

£430.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Payam Gammage

Institute: Cancer Research UK, Glasgow: The Beatson Institute

Tool Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: 143B m.8993T>G isogenic mTUNE mT70 Cell Line
  • Alternate name: mTUNE 7, mT7
  • Tool sub type: Continuous
  • Parental cell: 143B human osteosarcoma (m.8993T>G cybrid)
  • Organism: Human
  • Tissue: Bone
  • Disease: Cancer
  • Model: Tumour line
  • Description: The cellular metabolic environemnt is influenced by relative levels of coexistant mutant and wild-type mitochondrial DNAs (heteorplasmy) in a range of diseases for which mitochondrial dysfunction is a feature. Disease phenotypes may be rescued by returning heteroplasmy towards wild-type levels. To investigate this approach, the team led by Payam Gammage have devised a series of cell lines which stably express stable levels of mutatnt m.8993T>G mtDNA heteroplasmy. Cell lines bearing m.8993T>G heteroplasmy of 70 and 10% are available at CancerTools.org. These lines are derivatives of the m.8993T cybrid cell developed by Prof Eric Schon, and are of of 143B human osteosarcoma lineage. This is part of a series of two cell line (mTUNE); see Related research tools tab.
  • Production details: mTUNE cells were generated by Dr Michal Minczukâ?‚€?‚™s lab and derive from female human osteosarcoma 143B (RRID: CVCL_2270) cybrid cells (Porteous et al., 1998), after correction of m.8993T>G mutation with mitochondrially-targeted zinc finger nucleases (Gammage et al., 2016a). See Gaude et al., 2018 for further details.
  • Additional notes: This is part of a series of two cell line (mTUNE); see Related Reagents tab.

Handling

  • Format: Frozen
  • Growth medium: high glucose DMEM media supplemented with L-glutamine and 10S and pen/strep
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Subculture routine: Grow in regular dishes or flasks (10cm dish or 75cm2 flask). Passage 2 or 3 times a week, split when confluent (wash with PBS and then use trypsin to split). There is no maximum passage number. 1:10 for 3 splits a week, 1:20 Friday to Monday

Related Tools

  • Related tools: 143B m.8993T>G isogenic mTUNE mT10 Cell Line

References

  • Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo.
  • Enhanced Manipulation of Human Mitochondrial DNA Heteroplasmy In Vitro Using Tunable mtZFN Technology.
  • NADH Shuttling Couples Cytosolic Reductive Carboxylation of Glutamine with Glycolysis in Cells with Mitochondrial Dysfunction.
  • Engineered mtZFNs for Manipulation of Human Mitochondrial DNA Heteroplasmy.
  • Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs....

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.